Search / 102 results found

from
to
  • Updated

FRIDAY, Jan. 14, 2022 (HealthDay News) -- The nomination of former U.S. Food and Drug Administration head Robert Califf, M.D., to again lead the agency now heads to the full Senate for a vote, after a Senate committee on Thursday voted 13-8 for approval.

  • Updated

FRIDAY, Jan. 7, 2022 (HealthDay News) -- Citing the rapid spread of the omicron variant and the need for protection against it, U.S. federal health officials are shortening the recommended time between the second dose of the Moderna vaccine and a booster shot from six months down to five.

FRIDAY, Jan. 7, 2022 (HealthDay News) -- Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial Alzheimer's drug Aduhelm. The drug's benefits are in question and its annual price tag tops $28,000.

  • Updated

THURSDAY, Jan. 6, 2022 (HealthDay News) -- The Abbott BinaxNOW and Quidel QuickVue -- two widely used rapid at-home COVID tests -- may sometimes fail to spot evidence of the Omicron variant in the first days after infection, even when people are carrying substantial levels of the virus, preliminary research suggests.

TUESDAY, Jan. 4, 2022 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention on Tuesday backed the emergency use approval of Pfizer's booster shot for high-risk kids between the ages of 5 and 11, along with shortening the time period between a second dose and a booster shot from six months to five months.

  • Updated

SEATTLE, Jan. 4, 2022 /PRNewswire/ -- Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, announced today that Chief Executive Officer, Rolland Carlson, Ph.D., to present a corporate update, accessible on demand, at the virtual Biotech Showcase 2022 to be held Jan. 10-12 and Jan. 17–19, 2022.

  • Updated

CDC shortens isolation time for cases of asymptomatic COVID. With the Omicron variant causing a huge surge in cases and interruptions in Americans' lives, the agency on Monday shrank the time recommended for isolation in asymptomatic cases to five days, down from the previous 10. Read more

  • Updated

WASHINGTON, Dec. 15, 2021 /PRNewswire/ -- The 2021 Monitoring the Future survey results released today provide fresh evidence that youth e-cigarette use remains a serious public health problem in the United States, with nearly 1 in 5 high school seniors (19.6%) reporting that they vaped nicotine in the past month (considered current use). While this is a decline since youth e-cigarette rates peaked in 2019, it is nearly the same level as in 2018 (20.9%) when the U.S. Surgeon General, the FDA and other public health authorities declared youth e-cigarette use to be a public health epidemic.